1,198
Views
0
CrossRef citations to date
0
Altmetric
Oncology

The prognostic significance of skin involvement in breast cancer patients with chest wall recurrence

, , , , , & show all
Article: 2232299 | Received 19 Aug 2021, Accepted 28 Jun 2023, Published online: 11 Jul 2023

References

  • Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):1–13. doi: 10.3322/caac.21660.
  • Brackstone M, Fletcher GG, Dayes IS, et al. Locoregional therapy of locally advanced breast cancer: a clinical practice guideline. Curr Oncol. 2015;22(Suppl 1):S54–S66. doi: 10.3747/co.22.2316.
  • Wakeam E, Acuna SA, Keshavjee S. Chest wall resection for recurrent breast cancer in the modern era: a systematic review and meta-analysis. Ann Surg. 2018;267(4):646–655. doi: 10.1097/SLA.0000000000002310.
  • Elder EE, Kennedy CW, Gluch L, et al. Patterns of breast cancer relapse. Eur J Surg Oncol. 2006;32(9):922–927. doi: 10.1016/j.ejso.2006.06.001.
  • Maishman T, Cutress RI, Hernandez A, et al. Local recurrence and breast oncological surgery in young women with breast cancer: the POSH Observational Cohort Study. Ann Surg. 2017;266(1):165–172. doi: 10.1097/SLA.0000000000001930.
  • Haffty BG, Hauser A, Choi DH, et al. Molecular markers for prognosis after isolated postmastectomy chest wall recurrence. Cancer. 2004;100(2):252–263. doi: 10.1002/cncr.11915.
  • Hsi RA, Antell A, Schultz DJ, et al. Radiation therapy for chest wall recurrence of breast cancer after mastectomy in a favorable subgroup of patients. Int J Radiat Oncol Biol Phys. 1998;42(3):495–499. doi: 10.1016/s0360-3016(98)00254-5.
  • D’Aiuto M, Cicalese M, D’Aiuto G, et al. Surgery of the chest wall for involvement by breast cancer. Thorac Surg Clin. 2010;20(4):509–517. doi: 10.1016/j.thorsurg.2010.09.001.
  • van Tienhoven G, Voogd AC, Peterse JL, et al. Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group. Eur J Cancer. 1999;35(1):32–38. doi: 10.1016/s0959-8049(98)00301-3.
  • Recht A, Silen W, Schnitt SJ, et al. Time-course of local recurrence following conservative surgery and radiotherapy for early stage breast cancer. Int J Radiat Oncol Biol Phys. 1988;15(2):255–261. doi: 10.1016/s0360-3016(98)90002-5.
  • Elfgen C, Schmid SM, Tausch CJ, et al. Radiological staging for distant metastases in breast cancer patients with confirmed local and/or locoregional recurrence: how useful are current guideline recommendations? Ann Surg Oncol. 2019;26(11):3455–3461. doi: 10.1245/s10434-019-07629-9.
  • Chagpar A, Langstein HN, Kronowitz SJ, et al. Treatment and outcome of patients with chest wall recurrence after mastectomy and breast reconstruction. Am J Surg. 2004;187(2):164–169. doi: 10.1016/j.amjsurg.2003.11.006.
  • Nielsen HM, Overgaard M, Grau C, et al. Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies. J Clin Oncol. 2006;24(15):2268–2275. doi: 10.1200/JCO.2005.02.8738.
  • van der Pol CC, van Geel AN, Menke-Pluymers MBE, et al. Prognostic factors in 77 curative chest wall resections for isolated breast cancer recurrence. Ann Surg Oncol. 2009;16(12):3414–3421. doi: 10.1245/s10434-009-0662-7.
  • Ragaz J, Olivotto IA, Spinelli JJ, et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst. 2005;97(2):116–126. doi: 10.1093/jnci/djh297.
  • Chagpar A, Meric-Bernstam F, Hunt KK, et al. Chest wall recurrence after mastectomy does not always portend a dismal outcome. Ann Surg Oncol. 2003;10(6):628–634. doi: 10.1245/aso.2003.01.004.
  • Miyauchi K, Koyama H, Noguchi S, et al. Surgical treatment for chest wall recurrence of breast cancer. Eur J Cancer. 1992;28A(6–7):1059–1062. doi: 10.1016/0959-8049(92)90456-c.
  • Hu SCS, Chen GS, Lu YW, et al. Cutaneous metastases from different internal malignancies: a clinical and prognostic appraisal. J Eur Acad Dermatol Venereol. 2008;22(6):735–740. doi: 10.1111/j.1468-3083.2008.02590.x.
  • Saeed S, Keehn CA, Morgan MB. Cutaneous metastasis: a clinical, pathological, and immunohistochemical appraisal. J Cutan Pathol. 2004;31(6):419–430. doi: 10.1111/j.0303-6987.2004.00207.x.
  • Matejuk A. Skin immunity. Arch Immunol Ther Exp. 2018;66(1):45–54. doi: 10.1007/s00005-017-0477-3.
  • Agius E, Lacy KE, Vukmanovic-Stejic M, et al. Decreased TNF-alpha synthesis by macrophages restricts cutaneous immunosurveillance by memory CD4+ T cells during aging. J Exp Med. 2009;206(9):1929–1940. doi: 10.1084/jem.20090896.
  • Auffray C, Sieweke MH, Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol. 2009;27:669–692. doi: 10.1146/annurev.immunol.021908.132557.
  • Bedoui S, Whitney PG, Waithman J, et al. Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells. Nat Immunol. 2009;10(5):488–495. doi: 10.1038/ni.1724.
  • Ginhoux F, Collin MP, Bogunovic M, et al. Blood-derived dermal langerin + dendritic cells survey the skin in the steady state. J Exp Med. 2007;204(13):3133–3146. doi: 10.1084/jem.20071733.
  • Dieci MV, Tsvetkova V, Orvieto E, et al. Immune characterization of breast cancer metastases: prognostic implications. Breast Cancer Res. 2018;20(1):62. doi: 10.1186/s13058-018-1003-1.]
  • Gilhar A, Paus R, Kalish RS. Lymphocytes, neuropeptides, and genes involved in alopecia areata. J Clin Invest. 2007;117(8):2019–2027. doi: 10.1172/JCI131942.
  • Wang X, Marr AK, Breitkopf T, et al. Hair follicle mesenchyme-associated PD-L1 regulates T-cell activation induced apoptosis: a potential mechanism of immune privilege. J Invest Dermatol. 2014;134(3):736–745. doi: 10.1038/jid.2013.368.
  • Murakami T, Cardones AR, Hwang ST. Chemokine receptors and melanoma metastasis. J Dermatol Sci. 2004;36(2):71–78. doi: 10.1016/j.jdermsci.2004.03.002.
  • Kakinuma T, Hwang ST. Chemokines, chemokine receptors, and cancer metastasis. J Leukoc Biol. 2006;79(4):639–651. doi: 10.1189/jlb.1105633.
  • Müller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001;410(6824):50–56. doi: 10.1038/35065016.
  • Marneros AG, Blanco F, Husain S, et al. Classification of cutaneous intravascular breast cancer metastases based on immunolabeling for blood and lymph vessels. J Am Acad Dermatol. 2009;60(4):633–638. doi: 10.1016/j.jaad.2008.11.008.
  • Güth U, Wight E, Schötzau A, et al. Correlation and significance of histopathological and clinical features in breast cancer with skin involvement (T4b). Hum Pathol. 2006;37(3):264–271. doi: 10.1016/j.humpath.2005.11.009.
  • Cunningham JE, Jurj AL, Oman L, et al. Is risk of axillary lymph node metastasis associated with proximity of breast cancer to the skin? Breast Cancer Res Treat. 2006;100(3):319–328. doi: 10.1007/s10549-006-9256-2.
  • Colpaert CG, Vermeulen PB, Van Beest P, et al. Cutaneous breast cancer deposits show distinct growth patterns with different degrees of angiogenesis, hypoxia and fibrin deposition. Histopathology. 2003;42(6):530–540. doi: 10.1046/j.1365-2559.2003.01629.x.
  • Elmi M, Wakeam E, Azin A, et al. Surgical morbidity of full-thickness chest wall resection for breast cancer: a retrospective study of a national database. J Surg Res. 2021;257:161–166. doi: 10.1016/j.jss.2020.07.061.
  • Merritt RE. Chest wall reconstruction without prosthetic material. Thorac Surg Clin. 2017;27(2):165–169. doi: 10.1016/j.thorsurg.2017.01.010.
  • Ibrahim N, Samuels B, Page R, et al. Multicenter phase II trial of ABI-007, an albumin-bound paclitaxel, in women with metastatic breast cancer. J Clin Oncol. 2005;23(25):6019–6026. doi: 10.1200/JCO.2005.11.013.
  • Martín M, Ruiz A, Muñoz M, et al. Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial. Lancet Oncol. 2007;8(3):219–225. doi: 10.1016/S1470-2045(07)70041-4.
  • Saunders Y, Stebbing J, Broadley K, et al. Recurrent locally advanced breast cancer: the treatment of chest wall disease with further chemotherapy. Clin Oncol. 2001;13(3):195–199. doi: 10.1053/clon.2001.9252.
  • Vassilomanolakis M, Koumakis G, Demiri M, et al. Vinorelbine and cisplatin for metastatic breast cancer: a salvage regimen in patients progressing after docetaxel and anthracycline treatment. Cancer Invest. 2003;21(4):497–504. doi: 10.1081/cnv-120022358.